Physician profile
Javed Iqbal
NPI 1235123605
$10,056.22
in general payments reported to CMS, 2019-2025
52 companies · $1,140 in 2025
The $1,140 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,565 · 2020: $747 · 2021: $1,263 · 2022: $1,208 · 2023: $1,072 · 2024: $1,060 · 2025: $1,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,203 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,202.61 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,963.11 | 2019-2024 | |
| Ucb, INC. | $672.84 | 2019-2025 | Nayzilam, Fintepla, Briviact |
| Abbvie INC. | $593.45 | 2021-2025 | |
| Biogen, INC. | $570.97 | 2019-2025 | Vumerity, Tysabri |
| Genentech USA, INC. | $455.67 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Alexion Pharmaceuticals, INC. | $426.80 | 2019-2025 | Ultomiris, Soliris |
| Upsher-Smith Laboratories LLC | $345.09 | 2019-2022 | |
| Emd Serono, INC. | $332.07 | 2019-2025 | Mavenclad |
| Neurocrine Biosciences, INC. | $330.25 | 2019-2025 | Ingrezza, Ongentys |
| Csl Behring | $311.33 | 2020-2025 | Hizentra, Privigen |
| Teva Pharmaceuticals USA, INC. | $281.58 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $262.07 | 2020-2025 | Rytary, Crexont, Ongentys 50mg Capsules 30 |
| Sunovion Pharmaceuticals INC. | $212.47 | 2019-2022 | |
| Eisai INC. | $193.57 | 2019-2025 | |
| Lundbeck LLC | $184.75 | 2020-2025 | Rexulti, Vyepti |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javed Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.